Comparison of efficacy, safety, and economy of recombinant and urinary follicle-stimulating hormone in women with a predicted normal response undergoing assisted reproductive technology
In women with a predicted normal response undergoing ART treatment, rFSH and uFSH result in similar CDR and incidence of moderate-to-severe OHSS. However, the rFSH leads to a higher cost of COS.
Authors
- Lu Fan (ORCID: https://orcid.org/0000-0002-7446-6730)
- Yan Zha (ORCID: https://orcid.org/0000-0002-8713-1665)
- Leizhen Xia
- Lifeng Tian (ORCID: https://orcid.org/0000-0003-1880-5811)
- Cai Li (ORCID: https://orcid.org/0000-0002-5132-1117)
- Houyang Chen (ORCID: https://orcid.org/0000-0002-1906-5619)
- Leixiang Xia
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Jiangxi Maternal and Child Health Hospital (CN)
- Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Ovarian Research
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1186/s13048-025-01800-5
- Citations
- 1
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Health Commission of Jiangxi Province